TABLE 4.
Linear regression analyses of variables contributing to AIx@75 in CKD patients
| Univariate linear regression | Multiple linear regression | |||
|---|---|---|---|---|
| Standardized β | P | Standardized β | P | |
| Age (per 10 years) | 0.251 | <.001 | 0.201 | .001 |
| Female | 0.071 | .256 | ||
| Current smoker | 0.006 | .930 | ||
| BMI (kg/m2) | −0.067 | .286 | ||
| SBP (mmHg) | 0.310 | <.001 | 0.246 | <.001 |
| DBP (mmHg) | 0.167 | .007 | ||
| Diabetes | 0.137 | .028 | ||
| eGFR (per 10 mL/min/1.73 m2) | −0.249 | <.001 | ||
| Urine protein (g/day) | 0.085 | .177 | ||
| Fasting blood glucose (mmol/L) | −0.024 | .707 | ||
| TC (mmol/L) | −0.050 | .426 | ||
| TG (mmol/L) | −0.012 | .846 | ||
| HDL (mmol/L) | −0.079 | .207 | ||
| LDL (mmol/L) | −0.046 | .466 | ||
| Osteocalcin (ng/mL) | 0.182 | .003 | 0.174 | .003 |
| 25(OH)D (ng/mL) | −0.023 | .715 | ||
| PTH (pg/mL) | 0.179 | .004 | ||
| ACEI/ARB use | 0.040 | .522 | ||
| Antiplatelet use | 0.058 | .354 | ||
| Statins use | 0.046 | .734 | ||
Note: Age, eGFR, and other factors with P < .1 in univariate linear regression were included in this multiple linear stepwise regression.